| Price | 0.00 |
| Price Change Today | 0.00 (0.00%) |
| P&P rating | ![]() |
| Zacks Rank | N/A - N/A |
| Open Price | $0.00 |
| Previous Close | $0.00 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $0.00 - $0.01 |
| Volume | 0 |
| EPIX Pharmaceuticals, Inc., based in Cambridge, MA, discovers and develops innovative pharmaceuticals for imaging that are designed to transform the diagnosis, treatment and monitoring of disease. They use their proprietary Target Visualization Technology to create imaging pharmaceuticals targeted at the molecular level, enabling physicians to use Magnetic Resonance Imaging to obtain detailed information about specific disease processes. The Company's lead product, MS-325, is the first imaging pharmaceutical specifically designed for Magnetic Resonance Angiography. | |




Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment